| Ausstehende Aktien | 11,034,775 shares |
| Insider-Aktien | 3.537.438 shares |
| Insider-Besitz | 32,06 % |
| Insider gesamt | 32 |
Insider-Stimmungswert
Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.
Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.
Aktualisierungshäufigkeit: Täglich
Führungskräfte-Stimmungswert
Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.
Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.
Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.
Aktualisierungshäufigkeit: Täglich
Wichtige Insider-Kennzahlen
Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.
Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).
Prozent des Streubesitzes von Insidern gekauft (Rang)
4844 out of 10752
Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.
Diagramm zum Insiderhandel
Brainstorm Cell Therapeutics Inc. Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.
Kennzahlen zu Insiderlisten und Rentabilität
Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.
See our leaderboard of most profitable insider traders.
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| ACC International Holdings Ltd. - | 67.053 | 4.470 | |
| ACCBT Corp. | 3.181.925 | ||
| Irit Arbel Director - [D] | 161.054 | 161.054 | |
| Sankesh Abbhi Director - [D] | 11.323 | 755 | |
| June Sherie Almenoff Director - [D] | 6.000 | 400 | |
| Arturo Araya Chief Commercial Officer - [O] | 8.608 | 574 | |
| Menghisteab Bairu Director - [D] | 24.000 | 24.000 | |
| Yoram Bibring Chief Financial Officer - [O] | 50.000 | 3.333 | |
| Dagher Ibrahim B. Chief Medical Officer - [O] | 535.742 | 535.742 | |
| Jacob A Frenkel Director - [D] | 243.777 | 243.777 |
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Fiorino Anthony S. Chief Executive Officer - [O] | 2.500 | 167 | |
| Mordechai Friedman Director - [D] | 0 | 0 | |
| Hartoun Hartounian EVP, Chief Operating Officer - [O] | 52.000 | 52.000 | |
| Adrian Harel | 70.000 | ||
| Avi Israeli | 133.334 | ||
| Kern Ralph Dr. COO and Chief Medical Officer - [O] | 223.310 | 14.887 | |
| Chaim Lebovits President & CEO - [O] | 2.000.960 | 2.000.960 | |
| Stacy Lindborg Director - [D] | 48.229 | 48.229 | |
| Nir Naor Director - [D] | 31.465 | 31.465 | |
| Alla Patlis See Remarks - [O] | 144.349 | 144.349 | |
| Alon Pinkas | 15.333 |
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Polverino Anthony J. Director - [D] | 25.730 | 25.730 | |
| Eyal Rubin CFO and Treasurer - [O] | 25.000 | 1.667 | |
| Robert G L Shorr Director - [D] | 45.731 | 3.049 | |
| Chen Schor Director - [D] | 121.558 | 8.104 | |
| David Setboun EVP and COO - [O] | 55.000 | 3.667 | |
| Preetam Shah EVP, CFO and Treasurer - [O] | 11.600 | 773 | |
| Liat Sossover | 100.000 | ||
| Malcolm S Taub Director - [D] | 77.332 | 5.155 | |
| Kirk Taylor Chief Medical Officer - [O] | 35.000 | 2.333 | |
| Anthony Waclawski See Remarks - [O] | 35.000 | 2.333 | |
| Uri Yablonka EVP & Chief Business Officer, Director - [D] [O] | 218.464 | 218.464 |
Report errors via our new Insider Auditing Tool
Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in BCLI / Brainstorm Cell Therapeutics Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in BCLI / Brainstorm Cell Therapeutics Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Transaktionshistorie
Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.
| Datei Datum |
Handel Datum |
Form | Insider | Ticker | Wertpapier-Titel | Code | Direkt | Ausführung Preis |
Einheit Preis |
Eimheiten Verändert |
Wert Geändert (1K) |
Verbleibende Optionen |
Verbleibende Aktien |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | 2026-02-26 | 4 | Patlis Alla | BCLI | Common Stock | D | 100.000 | 144.349 | ||||||
| 2026-05-29 | 2026-02-26 | 4 | Yablonka Uri | BCLI | Common Stock | D | 150.000 | 218.464 | ||||||
| 2026-05-29 | 2026-02-26 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 1.800.000 | 2.000.960 | ||||||
| 2026-05-29 | 2026-02-26 | 4 | ARBEL IRIT | BCLI | Common Stock | D | 120.000 | 161.054 | ||||||
| 2026-05-29 | 2026-02-26 | 4 | FRENKEL JACOB A | BCLI | Common Stock | D | 200.000 | 243.777 | ||||||
| 2025-01-07 | 2025-01-01 | 4 | Dagher Ibrahim B. | BCLI | Common Stock | D | 50.000 | 66.849 | ||||||
| 2025-01-07 | 3/A | Dagher Ibrahim B. See Note | BCLI | Common Stock | I | 30.000 | ||||||||
| 2025-01-07 | 3/A | Dagher Ibrahim B. | BCLI | Common Stock | D | 315.742 | ||||||||
| 2025-01-07 | 3/A | Dagher Ibrahim B. By the Reporting Person's Roth IRA | BCLI | Common Stock | I | 160.000 | ||||||||
| 2025-01-03 | 2025-01-01 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 120.000 | 200.960 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | FRENKEL JACOB A | BCLI | Common Stock | D | 40.000 | 43.777 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 24.000 | 25.730 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Yablonka Uri | BCLI | Common Stock | D | 20.000 | 68.464 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Yablonka Uri | BCLI | Common Stock | D | 40.000 | 48.464 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Naor Nir | BCLI | Common Stock | D | 30.666 | 31.465 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Patlis Alla | BCLI | Common Stock | D | 40.000 | 44.349 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | HARTOUNIAN HARTOUN | BCLI | Common Stock | D | 50.000 | 52.000 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 20.000 | 48.229 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Bairu Menghisteab | BCLI | Common Stock | D | 24.000 | 24.000 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | ARBEL IRIT | BCLI | Common Stock | D | 30.666 | 41.054 | ||||||
| 2024-10-02 | 2024-10-01 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 3,4272 | 1.836 | 6 | 80.960 | ||||
| 2024-10-02 | 2024-09-30 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,2280 | 22.000 | 5 | 1.186.865 | ||||
| 2024-07-31 | 2024-05-22 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,6400 | 25.000 | 16 | 1.149.865 | ||||
| 2024-07-31 | 2024-05-21 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,5790 | 25.000 | 14 | 1.124.865 | ||||
| 2024-07-31 | 2024-05-28 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,5183 | 15.000 | 8 | 1.164.865 | ||||
| 2024-07-31 | 2024-05-13 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,4900 | 10.000 | 5 | 1.099.865 | ||||
| 2024-07-31 | 2024-05-11 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,4665 | 10.000 | 5 | 1.089.865 | ||||
| 2024-07-31 | 2024-05-10 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,4650 | 20.000 | 9 | 1.079.865 | ||||
| 2024-07-31 | 2024-05-06 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,3753 | 135.000 | 51 | 993.565 | ||||
| 2024-07-31 | 2024-05-07 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,3743 | 66.300 | 25 | 1.059.865 | ||||
| 2024-07-31 | 2024-04-19 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,5199 | 15.000 | 8 | 858.565 | ||||
| 2024-07-31 | 2024-04-18 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,5255 | 115.072 | 60 | 843.565 | ||||
| 2024-07-31 | 2024-04-17 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,5457 | 130.000 | 71 | 728.493 | ||||
| 2024-07-24 | 2024-07-19 | 4 | Dagher Ibrahim B. | BCLI | Common Stock | D | 0,3503 | -63.000 | -22 | 0 | ||||
| 2024-06-25 | 2024-06-24 | 4 | HARTOUNIAN HARTOUN | BCLI | Common Stock | D | 30.000 | 30.000 | ||||||
| 2024-06-03 | 2024-05-28 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,5183 | 15.000 | 8 | 1.164.865 | ||||
| 2024-05-23 | 2024-05-22 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,6400 | 25.000 | 16 | 1.149.865 | ||||
| 2024-05-23 | 2024-05-21 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,5790 | 25.000 | 14 | 1.124.865 | ||||
| 2024-05-14 | 2024-05-13 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,4900 | 10.000 | 5 | 1.099.865 | ||||
| 2024-05-14 | 2024-05-11 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,4665 | 10.000 | 5 | 1.089.865 | ||||
| 2024-05-14 | 2024-05-10 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,4650 | 20.000 | 9 | 1.079.865 | ||||
| 2024-05-07 | 2024-05-07 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,3743 | 66.300 | 25 | 1.059.865 | ||||
| 2024-05-07 | 2024-05-06 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,3753 | 135.000 | 51 | 993.565 | ||||
| 2024-04-25 | 2024-04-19 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,5199 | 15.000 | 8 | 858.565 | ||||
| 2024-04-22 | 3 | Dagher Ibrahim B. | BCLI | Common Stock | D | 63.000 | ||||||||
| 2024-04-22 | 3 | Dagher Ibrahim B. By the Reporting Person's Roth IRA | BCLI | Common Stock | I | 160.000 | ||||||||
| 2024-04-22 | 3 | Dagher Ibrahim B. See Note | BCLI | Common Stock | I | 30.000 | ||||||||
| 2024-04-19 | 2024-04-18 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,5255 | 115.072 | 60 | 843.565 | ||||
| 2024-04-19 | 2024-04-17 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,5457 | 130.000 | 71 | 728.493 | ||||
| 2024-03-13 | 2024-03-11 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 241.935 | 423.435 | ||||||
| 2024-03-13 | 2024-03-11 | 4 | Yablonka Uri | BCLI | Common Stock | D | 109.426 | 126.969 | ||||||
| 2024-03-13 | 2024-03-11 | 4 | Patlis Alla | BCLI | Common Stock | D | 65.246 | 65.246 | ||||||
| 2024-03-13 | 2024-03-11 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 305.198 | 598.493 | ||||||
| 2023-09-05 | 2023-09-01 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 1,7741 | 11.500 | 20 | 181.500 | ||||
| 2023-08-07 | 2023-08-02 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 35.000 | 170.000 | ||||||
| 2023-08-04 | 2023-08-02 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31.185 | 293.295 | ||||||
| 2023-06-21 | 2023-06-19 | 4 | Naor Nir | BCLI | Common Stock | D | 11.999 | 11.999 | ||||||
| 2023-05-01 | 2023-05-01 | 4 | Taylor Kirk | BCLI | Common Stock | D | 35.000 | 35.000 | ||||||
| 2023-04-24 | 2023-04-20 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 75.000 | 262.110 | ||||||
| 2023-04-24 | 2023-04-20 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 75.000 | 135.000 | ||||||
| 2023-01-04 | 2022-12-07 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 35.000 | 60.000 | ||||||
| 2023-01-04 | 2022-09-18 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31.185 | 187.110 | ||||||
| 2022-04-08 | 2022-04-06 | 4 | FRENKEL JACOB A | BCLI | Stock Option (right to buy) | D | 0,75 | 50.000 | 50.000 | |||||
| 2022-03-14 | 2022-03-06 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35.885 | 223.310 | ||||||
| 2022-02-03 | 2022-02-01 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 3.882 | 25.960 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 2.000 | 22.078 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 12.000 | 77.332 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Almenoff June Sherie | BCLI | Common Stock | D | 2.000 | 6.000 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,75 | 13.333 | 13.333 | |||||
| 2021-12-17 | 2021-12-15 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 25.333 | 25.333 | |||||
| 2021-12-10 | 2021-12-10 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35.885 | 187.425 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 12.000 | 65.332 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31.185 | 155.925 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 2.000 | 20.078 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 2.216 | 18.078 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 25.333 | 25.333 | |||||
| 2021-12-10 | 2021-12-10 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,75 | 13.333 | 13.333 | |||||
| 2021-12-10 | 2021-12-10 | 4 | Abbhi Sankesh | BCLI | Common Stock | D | 6.666 | 11.323 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | FRENKEL JACOB A | BCLI | Stock Option (right to buy) | D | 0,75 | 50.000 | 50.000 | |||||
| 2021-12-10 | 2021-12-10 | 4 | Almenoff June Sherie | BCLI | Common Stock | D | 2.000 | 4.000 | ||||||
| 2020-12-31 | 2020-12-30 | 4 | Shah Preetam | BCLI | Common Stock | D | 4,6400 | -25.000 | -116 | 11.600 | ||||
| 2020-11-19 | 2020-11-17 | 4 | Lindborg Stacy | BCLI | Call Option (right to buy) | D | 10,00 | 11.000,0000 | 200 | 2.200 | 200 | |||
| 2020-09-10 | 2020-09-08 | 4 | Waclawski Anthony | BCLI | Stock Option (Right to Buy) | D | 12,58 | 80.000 | 80.000 | |||||
| 2020-09-10 | 2020-09-08 | 4 | Waclawski Anthony | BCLI | Common Stock | D | 35.000 | 35.000 | ||||||
| 2020-07-31 | 2020-07-26 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31.185 | 124.740 | ||||||
| 2020-07-16 | 2020-07-15 | 4 | Abbhi Sankesh Abbhi Investments, LLC | BCLI | Common Stock | I | 12,9900 | 46.779 | 608 | 2.164.530 | ||||
| 2020-07-16 | 2020-07-16 | 4 | Setboun David | BCLI | Common Stock | D | 12,9480 | 5.000 | 65 | 55.000 | ||||
| 2020-07-16 | 2020-07-16 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 13,4668 | -7.823 | -105 | 67.053 | ||||
| 2020-07-16 | 2020-07-15 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 13,1153 | -18.430 | -242 | 74.876 | ||||
| 2020-07-16 | 2020-07-13 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 13,5238 | -40.000 | -541 | 93.306 | ||||
| 2020-07-16 | 2020-07-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 13,3500 | -2.000 | -27 | 133.306 | ||||
| 2020-07-16 | 2020-07-09 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 13,1253 | -3.500 | -46 | 135.306 | ||||
| 2020-06-26 | 2020-06-23 | 4 | Yablonka Uri | BCLI | Common Stock | D | 10.000 | 17.543 | ||||||
| 2020-06-01 | 2020-06-01 | 4 | Lindborg Stacy | BCLI | Stock Option (right to buy) | D | 7,67 | 100.000 | 100.000 | |||||
| 2020-06-01 | 2020-06-01 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 25.000 | 25.000 | ||||||
| 2020-04-07 | 2020-04-06 | 4 | FRENKEL JACOB A | BCLI | Stock Option (right to buy) | D | 0,75 | 50.000 | 50.000 | |||||
| 2020-04-07 | 2020-04-07 | 4 | Setboun David | BCLI | Common Stock | D | 50.000 | 50.000 | ||||||
| 2020-04-07 | 3 | Abbhi Sankesh Abbhi Investments, LLC | BCLI | Common Stock | I | 4.235.502 | ||||||||
| 2020-04-07 | 3 | Abbhi Sankesh Abbhi Investments, LLC | BCLI | Common Stock | I | 4.235.502 | ||||||||
| 2020-04-07 | 3 | Abbhi Sankesh Abbhi Investments, LLC | BCLI | Common Stock | I | 4.235.502 | ||||||||
| 2020-04-07 | 2020-04-06 | 4 | Abbhi Sankesh | BCLI | Common Stock | D | 4.657 | 4.657 | ||||||
| 2020-04-07 | 3 | FRENKEL JACOB A | BCLI | Common Stock | D | 113.334 | ||||||||
| 2020-04-07 | 3 | FRENKEL JACOB A | BCLI | Common Stock | D | 113.334 | ||||||||
| 2020-04-07 | 3 | FRENKEL JACOB A | BCLI | Common Stock | D | 113.334 | ||||||||
| 2020-03-13 | 2020-03-09 | 4 | Kern Ralph Dr. | BCLI | Stock Option (right to buy) | D | 7,33 | 80.000 | 80.000 | |||||
| 2020-03-06 | 2020-03-06 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35.885 | 151.540 | ||||||
| 2020-02-14 | 2019-12-12 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 25.333 | 25.333 | |||||
| 2020-02-14 | 2019-12-12 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 12.000 | 53.332 | ||||||
| 2020-02-14 | 2019-12-12 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,75 | 13.333 | 13.333 | |||||
| 2020-02-14 | 2019-12-12 | 4 | Almenoff June Sherie | BCLI | Common Stock | D | 2.000 | 2.000 | ||||||
| 2020-02-14 | 2020-02-01 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 3.071 | 15.862 | ||||||
| 2020-02-14 | 2019-12-12 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 2.000 | 12.791 | ||||||
| 2019-12-27 | 2019-12-24 | 4 | Araya Arturo | BCLI | Common Stock | D | 3,9000 | 3.000 | 12 | 8.608 | ||||
| 2019-12-27 | 2019-12-24 | 4 | Shah Preetam | BCLI | Common Stock | D | 3,9594 | 11.600 | 46 | 36.600 | ||||
| 2019-12-27 | 2019-12-24 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 3,8800 | 3.000 | 12 | 115.655 | ||||
| 2019-09-09 | 2019-09-06 | 4 | Shah Preetam | BCLI | Stock Option (right to buy) | D | 3,96 | 100.000 | 100.000 | |||||
| 2019-09-09 | 2019-09-06 | 4 | Shah Preetam | BCLI | Stock Option (right to buy) | D | 6,00 | 100.000 | 100.000 | |||||
| 2019-09-09 | 2019-09-06 | 4 | Shah Preetam | BCLI | Common Stock | D | 25.000 | 25.000 | ||||||
| 2019-08-30 | 2019-08-28 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 2,25 | -6.666 | 0 | |||||
| 2019-08-30 | 2019-08-28 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 2,25 | -6.666 | 0 | |||||
| 2019-08-30 | 2019-08-28 | 4 | ARBEL IRIT | BCLI | Common Stock | D | 3,6672 | -13.332 | -49 | 155.833 | ||||
| 2019-08-30 | 2019-08-28 | 4 | ARBEL IRIT | BCLI | Common Stock | D | 2,2500 | 6.666 | 15 | 169.165 | ||||
| 2019-08-30 | 2019-08-28 | 4 | ARBEL IRIT | BCLI | Common Stock | D | 2,2500 | 6.666 | 15 | 169.165 | ||||
| 2019-07-26 | 2019-07-26 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31.185 | 2.166.155 | ||||||
| 2019-03-08 | 2019-03-06 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35.885 | 112.655 | ||||||
| 2019-02-22 | 2019-02-01 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 3.501 | 10.791 | ||||||
| 2019-01-08 | 2019-01-04 | 4 | Almenoff June Sherie By Meadowlark Management LLC | BCLI | Common Stock | I | 3,3900 | 1.475 | 5 | 7.175 | ||||
| 2018-12-21 | 2018-10-24 | 4 | Schor Chen By The C. Schor Irrevocable Trust | BCLI | Common Stock | I | 121.558 | 121.558 | ||||||
| 2018-12-21 | 2018-10-24 | 4 | Schor Chen | BCLI | Common Stock | D | -121.558 | 4.000 | ||||||
| 2018-11-30 | 2018-11-30 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 12.000 | 41.332 | ||||||
| 2018-11-30 | 2018-11-30 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,75 | 13.333 | 13.333 | |||||
| 2018-11-30 | 2018-11-30 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 25.333 | 25.333 | |||||
| 2018-11-30 | 2018-11-30 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 1.667 | 7.290 | ||||||
| 2018-11-30 | 2018-11-30 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 2.000 | 5.623 | ||||||
| 2018-11-30 | 2018-11-30 | 4 | Schor Chen | BCLI | Common Stock | D | 2.000 | 125.558 | ||||||
| 2018-09-04 | 2018-08-28 | 4 | Araya Arturo | BCLI | Stock Option (right to buy) | D | 3,98 | 200.000 | 200.000 | |||||
| 2018-09-04 | 2018-08-28 | 4 | Araya Arturo | BCLI | Common Stock | D | -2.805 | 5.608 | ||||||
| 2018-07-27 | 2018-07-26 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31.185 | 2.134.970 | ||||||
| 2018-03-26 | 2018-03-06 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35.885 | 76.770 | ||||||
| 2018-03-26 | 2018-03-26 | 4 | Araya Arturo | BCLI | Common Stock | D | 1.249 | 8.413 | ||||||
| 2018-03-20 | 2018-03-15 | 4/A | Kern Ralph Dr. | BCLI | Common Stock | D | 3,5994 | 5.000 | 18 | 40.885 | ||||
| 2018-03-20 | 2018-03-15 | 4/A | Almenoff June Sherie By Meadowlark Management LLC | BCLI | Common Stock | I | 3,5000 | 5.700 | 20 | 5.700 | ||||
| 2018-03-19 | 2018-03-15 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 3,5994 | 5.000 | 18 | 40.885 | ||||
| 2018-03-16 | 2018-03-15 | 4 | Almenoff June Sherie By Meadowlark Management LLC | BCLI | Common Stock | I | 3,5000 | 5.700 | 20 | 5.700 | ||||
| 2018-02-28 | 2018-02-26 | 4 | Araya Arturo | BCLI | Common Stock | D | 4.152 | 7.164 | ||||||
| 2018-02-05 | 2018-02-01 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 3.623 | 3.623 | ||||||
| 2017-11-20 | 2017-11-20 | 4 | Rubin Eyal | BCLI | Stock Option (right to buy) | D | 4,30 | 93.686 | 93.686 | |||||
| 2017-11-20 | 2017-11-20 | 4 | Rubin Eyal | BCLI | Common Stock | D | 25.000 | 25.000 | ||||||
| 2017-11-13 | 2017-11-10 | 4 | Schor Chen | BCLI | Common Stock | D | 2.000 | 123.558 | ||||||
| 2017-11-13 | 2017-11-10 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 12.000 | 29.332 | ||||||
| 2017-11-13 | 2017-11-10 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,75 | 13.333 | 13.333 | |||||
| 2017-11-13 | 2017-11-10 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 25.333 | 25.333 | |||||
| 2017-11-13 | 2017-11-10 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 8.666 | 45.731 | ||||||
| 2017-08-31 | 2017-08-31 | 4 | ARBEL IRIT | BCLI | Common Stock | D | 4,2600 | 2.500 | 11 | 155.833 | ||||
| 2017-08-23 | 2017-08-23 | 4 | Yablonka Uri | BCLI | Common Stock | D | 3,9800 | 2.000 | 8 | 7.543 | ||||
| 2017-07-26 | 2017-07-26 | 4 | Lebovits Chaim | BCLI | Stock Option (right to buy) | D | 4,81 | 41.580 | 41.580 | |||||
| 2017-07-26 | 2017-07-26 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31.185 | 2.103.785 | ||||||
| 2017-07-17 | 2017-07-13 | 4 | Yablonka Uri | BCLI | Common Stock | D | 5.543 | 5.543 | ||||||
| 2017-07-17 | 2017-07-13 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 12.000 | 12.000 | |||||
| 2017-03-06 | 2017-03-06 | 4 | Kern Ralph Dr. | BCLI | Stock Option (right to buy) | D | 4,18 | 47.847 | 47.847 | |||||
| 2017-03-06 | 2017-03-06 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35.885 | 35.885 | ||||||
| 2017-03-03 | 2017-02-26 | 4 | Araya Arturo | BCLI | Common Stock | D | 3.012 | 3.012 | ||||||
| 2017-02-28 | 2017-02-26 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 6.667 | 6.667 | |||||
| 2016-06-23 | 2016-06-22 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 8.666 | 37.065 | ||||||
| 2016-06-23 | 2016-06-22 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 25.333 | 25.333 | |||||
| 2016-06-23 | 2016-06-22 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 8.666 | 17.332 | ||||||
| 2016-06-23 | 2016-06-22 | 4 | Pinkas Alon | BCLI | Stock Option (right to buy) | D | 0,75 | 15.333 | 15.333 | |||||
| 2016-06-23 | 2016-06-22 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0,75 | 16.666 | 16.666 | |||||
| 2016-06-23 | 2016-06-22 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,75 | 13.333 | 13.333 | |||||
| 2015-12-17 | 2015-12-16 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 2,7100 | -10.800 | -29 | 28.399 | ||||
| 2015-12-16 | 2015-12-14 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0,75 | -5.000 | 11.666 | |||||
| 2015-12-16 | 2015-12-14 | 4 | Friedman Mordechai | BCLI | Common Stock | D | 2,5700 | -5.000 | -13 | 0 | ||||
| 2015-12-16 | 2015-12-14 | 4 | Friedman Mordechai | BCLI | Common Stock | D | 0,7500 | 5.000 | 4 | 5.000 | ||||
| 2015-12-16 | 2015-12-15 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 2,5900 | -11.263 | -29 | 8.666 | ||||
| 2015-12-16 | 2015-12-14 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 2,6100 | -30.479 | -80 | 19.929 | ||||
| 2015-12-14 | 2015-12-11 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 2,6600 | -980 | -3 | 50.408 | ||||
| 2015-12-14 | 2015-12-10 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 2,7400 | -12.500 | -34 | 51.388 | ||||
| 2015-12-14 | 2015-12-11 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 2,5600 | -5.300 | -14 | 39.199 | ||||
| 2015-12-14 | 2015-12-10 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 2,7100 | -5.500 | -15 | 44.499 | ||||
| 2015-12-03 | 2015-12-01 | 4 | Bibring Yoram | BCLI | Stock Option (right to buy) | D | 3,17 | 82.500 | 82.500 | |||||
| 2015-10-13 | 2015-09-28 | 4/A | Lebovits Chaim | BCLI | Stock Option (right to buy) | D | 2,45 | 369.619 | 369.619 | |||||
| 2015-10-02 | 2015-10-01 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 2,5800 | 2.000 | 5 | 138.806 | ||||
| 2015-10-01 | 2015-09-28 | 4 | Lebovits Chaim | BCLI | Stock Option (right to buy) | D | 2,45 | 369.619 | 369.619 | |||||
| 2015-10-01 | 2015-09-30 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 2,3400 | 9.200 | 22 | 136.806 | ||||
| 2015-08-31 | 2015-08-27 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 8.666 | 49.999 | ||||||
| 2015-08-31 | 2015-08-27 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,75 | 13.333 | 13.333 | |||||
| 2015-08-31 | 2015-08-27 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 8.666 | 50.554 | ||||||
| 2015-08-31 | 2015-08-27 | 4 | Pinkas Alon | BCLI | Stock Option (right to buy) | D | 0,75 | 15.333 | 15.333 | |||||
| 2015-08-31 | 2015-08-27 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0,75 | 16.666 | 16.666 | |||||
| 2015-08-31 | 2015-08-27 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 25.333 | 25.333 | |||||
| 2015-08-21 | 2015-08-20 | 4 | Bibring Yoram | BCLI | Common Stock | D | 3,0400 | 8.500 | 26 | 50.000 | ||||
| 2015-08-19 | 2015-08-17 | 4 | Bibring Yoram | BCLI | Common Stock | D | 2,9200 | 41.500 | 121 | 41.500 | ||||
| 2015-08-03 | 2015-07-30 | 4 | Bibring Yoram | BCLI | Stock Option (right to buy) | D | 3,17 | 165.000 | 165.000 | |||||
| 2015-06-03 | 2015-06-01 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 6.667 | 6.667 | |||||
| 2015-05-05 | 2015-05-03 | 4 | Schor Chen | BCLI | Common Stock | D | 60.000 | 121.558 | ||||||
| 2014-10-15 | 2014-10-15 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 3,5990 | 300 | 1 | 2.500 | ||||
| 2014-10-15 | 2014-10-15 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 3,5900 | 200 | 1 | 2.200 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3,9999 | 300 | 1 | 127.606 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3,9499 | 700 | 3 | 127.306 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3,9500 | 300 | 1 | 126.606 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0100 | 400 | 2 | 126.306 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3,9799 | 400 | 2 | 125.906 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3,9799 | 1.300 | 5 | 125.506 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0099 | 600 | 2 | 124.206 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0399 | 600 | 2 | 123.606 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0500 | 300 | 1 | 123.006 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0799 | 200 | 1 | 122.706 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0899 | 2.500 | 10 | 122.506 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,2900 | 1.000 | 4 | 120.006 | ||||
| 2014-10-01 | 2014-10-01 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0799 | 3.600 | 15 | 119.006 | ||||
| 2014-10-01 | 2014-09-30 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,3200 | 1.000 | 4 | 115.406 | ||||
| 2014-10-01 | 2014-09-30 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,2150 | 500 | 2 | 114.406 | ||||
| 2014-10-01 | 2014-09-29 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,1200 | 1.000 | 4 | 113.906 | ||||
| 2014-10-01 | 2014-09-29 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,1700 | 500 | 2 | 112.906 | ||||
| 2014-10-01 | 2014-09-29 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,1800 | 100 | 0 | 112.406 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,3000 | 1.800 | 8 | 112.306 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,2900 | 2.000 | 9 | 110.506 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,2800 | 400 | 2 | 108.506 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,2700 | 1.000 | 4 | 108.106 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,2300 | 1.200 | 5 | 107.106 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,2000 | 500 | 2 | 105.906 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,1800 | 300 | 1 | 105.406 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,1400 | 500 | 2 | 105.106 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,1000 | 300 | 1 | 104.606 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0500 | 500 | 2 | 104.306 | ||||
| 2014-09-24 | 2014-09-19 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3,9400 | 1.000 | 4 | 103.806 | ||||
| 2014-09-24 | 2014-09-19 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3,9000 | 1.500 | 6 | 102.806 | ||||
| 2014-09-19 | 2014-09-18 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 3,8400 | 800 | 3 | 2.000 | ||||
| 2014-09-16 | 2014-09-15 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 0,2835 | 3.000 | 1 | 18.000 | ||||
| 2014-09-16 | 2014-09-15 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 0,2875 | 5.000 | 1 | 15.000 | ||||
| 2014-09-16 | 2014-09-12 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 0,2850 | 7.500 | 2 | 10.000 | ||||
| 2014-09-16 | 2014-09-12 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 0,2800 | 2.500 | 1 | 2.500 | ||||
| 2014-08-19 | 2014-08-15 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 130.000 | 620.000 | ||||||
| 2014-08-19 | 2014-08-15 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,05 | 380.000 | 380.000 | |||||
| 2014-08-19 | 2014-08-15 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 130.000 | 628.333 | ||||||
| 2014-08-19 | 2014-08-15 | 4 | Pinkas Alon | BCLI | Stock Option (right to buy) | D | 0,05 | 230.000 | 230.000 | |||||
| 2014-08-19 | 2014-08-15 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0,05 | 250.000 | 250.000 | |||||
| 2014-08-19 | 2014-08-15 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,05 | 200.000 | 200.000 | |||||
| 2014-06-20 | 2014-06-16 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 0,2900 | 130.000 | 38 | 1.519.600 | ||||
| 2014-06-16 | 2014-06-13 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 0,3500 | 150.000 | 52 | 1.389.600 | ||||
| 2014-06-10 | 2014-06-09 | 4 | Fiorino Anthony S. | BCLI | Stock Option (right to buy) | D | 0,30 | 5.700.000 | 5.700.000 | |||||
| 2014-06-09 | 2014-06-06 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,18 | 500.000 | 500.000 | |||||
| 2014-05-02 | 2014-04-28 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 0,3000 | 939.600 | 282 | 1.239.600 | ||||
| 2014-04-14 | 2014-04-13 | 4 | Israeli Avi | BCLI | Stock Option (right to buy) | D | 133.334 | 133.334 | ||||||
| 2014-04-14 | 2014-04-13 | 4 | Israeli Avi | BCLI | Stock Option (right to buy) | D | 166.666 | 166.666 | ||||||
| 2014-01-03 | 2013-12-31 | 4 | Sossover Liat | BCLI | Stock Option (right to buy) | D | 0,18 | 100.000 | 100.000 | |||||
| 2013-04-23 | 2013-04-19 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 130.000 | 490.000 | ||||||
| 2013-04-23 | 2013-04-19 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,15 | 180.000 | 180.000 | |||||
| 2013-04-23 | 2013-04-19 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 130.000 | 498.333 | ||||||
| 2013-04-23 | 2013-04-13 | 4 | Israeli Avi | BCLI | Stock Option (right to buy) | D | 166.666 | 166.666 | ||||||
| 2013-04-23 | 2013-04-19 | 4 | Pinkas Alon | BCLI | Stock Option (right to buy) | D | 0,15 | 130.000 | 130.000 | |||||
| 2013-04-23 | 2013-04-19 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0,15 | 150.000 | 150.000 | |||||
| 2012-09-06 | 2012-08-01 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,15 | 180.000 | 180.000 | |||||
| 2012-09-06 | 2012-08-01 | 4 | Pinkas Alon | BCLI | Stock Option (right to buy) | D | 0,15 | 130.000 | 130.000 | |||||
| 2012-09-06 | 2012-08-01 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0,15 | 150.000 | 150.000 | |||||
| 2012-08-27 | 2012-08-01 | 4/A | Harel Adrian | BCLI | Stock Option (right to buy) | D | 0,26 | 70.000 | 70.000 | |||||
| 2012-08-27 | 2012-08-01 | 4/A | Sossover Liat | BCLI | Stock Option (right to buy) | D | 0,26 | 60.000 | 60.000 | |||||
| 2012-08-03 | 2012-08-01 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 130.000 | 360.000 | ||||||
| 2012-08-03 | 2012-08-01 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 130.000 | 368.333 | ||||||
| 2012-08-03 | 2012-08-01 | 4 | Sossover Liat | BCLI | Stock Option (right to buy) | D | 0,26 | 60.000 | 60.000 | |||||
| 2012-08-03 | 2012-08-01 | 4 | Harel Adrian | BCLI | Stock Option (right to buy) | D | 0,26 | 70.000 | 70.000 | |||||
| 2012-04-17 | 2012-04-13 | 4 | Israeli Avi | BCLI | Stock Option (right to buy) | D | 166.666 | 166.666 | ||||||
| 2009-04-03 | 3 | TAUB MALCOLM S | BCLI | Common Stock | D | 1.250.000 | ||||||||
| 2007-08-08 | 2007-08-02 | 4 | ACCBT Corp. | BCLI | Right to Acquire Warrant to Purchase Common Stock | D | 636.385,00 | 3.181.925 | 3.181.925 |
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
